三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
ROS1靶点药物国内竞争格局(II期及以上)
ROS1靶点药物国内竞争格局(II期及以上)
竞争格局
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:255KB
图片尺寸:2314*1069
同报告图片
/
4
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
fCDoja/lk4HlkI3np7AgfCDpnbbngrkgfCDnoJTlj5HmnLrmnoQgfCDnlr7nl4UgfCDkuK3lm73pmLbmrrUgfAp8IC0tLSB8IC0tLSB8IC0tLSB8IC0tLSB8IC0tLSB8Cnwg5LuR5LyQ5pu/5bC8IHwgUkVUO2MtS2l0O1ZFR0ZSO1BER0ZSzrE7RkdGUiB8IE1lcmNrICYgQ28uO0Vpc2FpIHwg5YiG5YyW5Z6L55Sy54q26IW655mM562JIHwg5om55YeG5LiK5biCIHwKfCDmma7mi4nmm7/lsLwgfCBSRVQgfCDln7rnn7Poja/kuJo7UmlnZTtCbHVlcHJpbnQ7Um9jaGUgfCDpnZ7lsI/nu4bog57ogrrnmYznrYkgfCDmibnlh4bkuIrluIIgfAp8IOeRnuaIiOmdnuWwvCB8IEZHRlI7VkVHRlI7Yy1LaXQ7UERHRlI7QlJBRuetieWkmumdtueCuSB8IEJheWVyO09ueXggUGhhcm1hY2V1dGljYWxzKEFtZ2VuKSB8IOe7k+ebtOiCoOeZjOetiSB8IOaJueWHhuS4iuW4giB8Cnwg57Si5ouJ6Z2e5bC8IHwgVkVHRlI7Yy1LaXQ7UERHRlLOsjtCUkFGO1JFVOetieWkmumdtueCuSB8IEJheWVyO09ueXggUGhhcm1hY2V1dGljYWxzKEFtZ2VuKSB8IOiCvue7huiDnueZjOetiSB8IOaJueWHhuS4iuW4giB8Cnwg6Zi/5p2l5pu/5bC8IHwgUkVUO0FMSyB8IENodWdhaSBQaGFybWFjZXV0aWNhbCB8IOmdnuWwj+e7huiDnuiCuueZjOetiSB8IOaJueWHhuS4iuW4giB8Cnwg6IiS5bC85pu/5bC8IHwgYy1LaXQ7UkVUO1ZFR0ZSO1BER0ZSzrI7Rmx0M+etieWkmumdtueCuSB8IFN1Z2VuKFBmaXplcikgfCDogr7nu4bog57nmYznrYkgfCDmibnlh4bkuIrluIIgfAp8IOWhnuaZruabv+WwvCB8IFJFVCDmipHliLbliYIgfCBFbGkgTGlsbHk7UGZpemVyO+S/oei+vueUn+eJqSB8IOmdnuWwj+e7huiDnuiCuueZjOetiSB8IOaJueWHhuS4iuW4giB8Cnwg5rOK6YKj5pu/5bC8IHwgQmNyLUFibCBUMzE1STtGR0ZSO1JFVDtjLUtpdDtGbHQzIHwgVGFrZWRhIFBoYXJtYWNldXRpY2FscztPdHN1a2E7SW5jeXRlIHwg5oWi5oCn6auT57O755m96KGA55eF562JIHwg55Sz6K+35LiK5biCIHwKfCDljaHljZrmm7/lsLwgfCBSRVQ7VkVHRlI7Yy1NZXQ7Yy1LaXQ7QXhs562J5aSa6Z2254K5IHwgSXBzZW47VGFrZWRhIFBoYXJtYWNldXRpY2FscztFeGVsaXhpcztCTVMgfCDpq5PmoLfnlLLnirbohbrnmYznrYkgfCDnlLPor7fkuIrluIIgfAoK6LWE5paZ5p2l5rqQ77ya5Yy76I2v6a2U5pa577yM5Y2O5rqQ6K+B5Yi456CU56m2
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
所属报告:
信达生物-港股公司研究报告:肿瘤与综合线双驱动造就创新旗舰Biopharma-241020(44页).pdf
打包全文图表
相关数据
图28、奈克替尼与竞品在CD74融合ROS1阳
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
收藏
行业数据
2025-08-19
原图定位
查看详情
全球范围内共11款ROS1、ALK靶向药获批(截至2024.9.13)
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
收藏
行业数据
2024-09-14
原图定位
查看详情
国内外获批上市ROS1抑制剂梳理
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
收藏
其它
2024-07-10
原图定位
查看详情
ROS1TKI数据对比
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
收藏
行业数据
2023-03-07
原图定位
查看详情
主要ROS1/ALK/TRK小分子靶向药1L治疗ROS1+NSCLC临床数据对比
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
收藏
行业数据
2022-12-06
原图定位
查看详情
国内ROS1/TRK靶向药物竞争格局
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
收藏
行业数据
2021-08-16
原图定位
查看详情
国内用于治疗ROS1基因重排的ROS1、TRK抑制剂研发进展
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
收藏
行业数据
2021-07-09
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
2024 年 3 月,一线治疗上述适应症的 NDA 也被受理,有望为非小细胞肺癌患者带来潜在获益。
竞争格局
原图定位
当前图表所属:
信达生物-港股公司研究报告:肿瘤与综合线双驱动造就创新旗舰Biopharma-241020(44页).pdf
RET靶点药物的国内竞争格局(NDA及以上)
VEGF/VEGFR靶点单抗药物的国内竞争格局(III期及以上)
Bcr-Abl靶点药物的国内竞争格局(III期及以上)
利妥昔单抗国内竞争格局(NDA及以上)
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》